NCT07032584 Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
| NCT ID | NCT07032584 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Prostate Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 74 participants |
| Start Date | 2025-05-27 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 74 participants in total. It began in 2025-05-27 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
People with prostate cancer may have a decreased quality of life due to the cancer itself and due to a lifesaving cancer treatment. Physical therapy, including regular exercise, helps patients with cancer to reduce disease symptoms and improve their quality of life. However, cancer rehabilitation programs in rural areas are not readily available and may require constant travel and significant financial resources, which may limit access to these services on a continuous basis. Technology can allow patients residing in rural areas to exercise at home under the supervision of their rehabilitation team. However, it is unclear how effective this approach is. This research team will conduct a clinical trial in which half of the randomly chosen participants receiving hormonal prostate cancer therapy will use this new technology to exercise at home. Another half - will exercise at home without this new technology. After six months, the study will compare the quality of life and cancer symptoms in these two groups. The investigators hope that this study will demonstrate that the patients who were helped by the new technology to exercise at home will have better fitness, fewer symptoms, and better quality of life. If the study demonstrates this in this project, other patients with cancer residing in rural areas will be able to take advantage of this technology. This approach can be extended to people with different diseases who have difficulties accessing medical care in rural areas to undergo required physical, cognitive, and occupational rehabilitation, and improve their quality of life.
Eligibility Criteria
Inclusion Criteria: 1. Age 21 years or older 2. Confirmed diagnosis of prostate cancer 3. Men receiving standard-of-care ADT either for high-risk, locally advanced prostate cancer or as a part of multicomponent management of metastatic prostate cancer; 4. Residing in a rural community defined by the Rural-Urban Commuting Area (RUCA) codes from the Federal Office of Rural Health Policy (4 and higher). Exclusion Criteria: 1. Have unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers, painful or unstable bony metastases, or recent skeletal fractures. 2. Are engaged in a regular exercise rehabilitation program. 3. Have relocation plans within the next 6 months 4. Participate in another clinical trial related to prostate cancer or rehabilitation. The patients will also be required to have a working telephone line in their home or a cell phone.
Contact & Investigator
Manish Kohli, MD
PRINCIPAL INVESTIGATOR
University of Utah
Frequently Asked Questions
Who can join the NCT07032584 clinical trial?
This trial is open to male participants only, aged 21 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07032584 currently recruiting?
Yes, NCT07032584 is actively recruiting participants. Contact the research team at Manish.Kohli@hci.utah.edu for enrollment information.
Where is the NCT07032584 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT07032584 clinical trial?
NCT07032584 is sponsored by University of Utah. The principal investigator is Manish Kohli, MD at University of Utah. The trial plans to enroll 74 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.